What people try, and what the evidence shows
These are the interventions that come up most in patient discussion. We cover what each one is, what the evidence establishes, and what it costs.
Start with what it costs
The short answer
A two week cash course of the standard prescription runs about $2,200 to $2,940 in the US without insurance. That single number drives most of the searching in this subject: people look for alternatives because of the price, not because the alternatives are better documented. Every page below says what the evidence does and does not establish.The interventions
Probiotics: genuinely contested, and we will say soSome clinicians use them here, others argue they make things worse in this specific situation. That disagreement is real and this page does not resolve it.
Oregano, berberine and allicin: the evidenceThese three dominate patient discussion of herbal options. What the evidence supports, and why comparing one brand against another does not work.
Rifaximin: what it is and what it costsWhat it is, what a two week cash course costs in the US, and what happens when it does not work. The price is the reason most people are reading this.
Activated charcoal and bindersCharcoal is genuinely non-selective, which is the whole point in poisoning and the whole problem everywhere else. Absorption interference is the buried fact.
Biofilms: high discussion, thin evidenceBiofilms are real microbiology. The gap between what is established and what is sold as a biofilm protocol is the widest we found anywhere in this niche.
Prokinetics and the relapse questionRecurrence is common enough that it shapes how people think here. Prokinetics are the usual answer, and the evidence for that use is thin.
Elemental formula: what it is and what it costsA pre-digested liquid formula used as a total food replacement. Real clinical use, real difficulty, and a price most pages do not mention.
DAO supplements and the 100x label problemPorcine and plant products publish potency figures that differ by a hundredfold. That gap is an assay artefact, not potency, and almost nobody says so.
What this actually costs, end to endTesting, prescription and repeat rounds, with every figure dated. The prescription cash price is why most people are reading about alternatives at all.
How we decide what to say about any of this
Every source carries a label showing how strong it is, so a conference abstract never reads like a clinical guideline. Where the evidence is thin we say it is thin rather than filling the gap with confidence. Our full methodology.
Why there are no protocols here
No dosing and no protocols, for anything. Where a manufacturer’s own lawyers declined to make a claim, we are not going to make it for them. None of this is medical advice and we are not clinicians. Take any of it to someone who can examine you.